Form 8-K - Current report:
SEC Accession No. 0001521536-12-000160
Filing Date
2012-03-01
Accepted
2012-03-01 17:09:55
Documents
5
Period of Report
2012-02-24
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 q1100382_8k-biozone.htm 8-K 32694
2 FORM OF SUBSCRIPTION AGREEMENT q1100382_ex10-1.htm EX-10.1 178467
3 FORM OF NOTE q1100382_ex10-2.htm EX-10.2 53975
4 FORM OF WARRANT q1100382_ex10-3.htm EX-10.3 121309
5 SECURITY AND STOCK PLEDGE AGREEMENT q1100382_ex10-4.htm EX-10.4 282635
  Complete submission text file 0001521536-12-000160.txt   670481
Mailing Address 4400 BISCAYNE BLVD SUITE 850 MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD SUITE 850 MIAMI FL 33137 800-689-0930
BIOZONE PHARMACEUTICALS, INC. (Filer) CIK: 0001412486 (see all company filings)

IRS No.: 205978559 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-146182 | Film No.: 12658792
SIC: 2834 Pharmaceutical Preparations